Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Vaginal microbiome of reproductive-age women
2010 Standout
Human papillomavirus testing for primary screening of cervical cancer precursors.
2000
Cancer statistics, 2023
2023 Standout
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
2004 StandoutNobel
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
2003 Standout
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
Microbiota in health and diseases
2022 Standout
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
2003
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
2001
Cancer statistics, 2024
2024 Standout
HPV testing in cervical screening
2001
Expanding global access to radiotherapy
2015 Standout
Smoking and the antioxidant ascorbic acid: Plasma, leukocyte, and cervicovaginal cell concentrations in normal healthy women
1990
Cancer burden in the year 2000. The global picture
2001 Standout
The epidemiology of human papillomavirus infections
2005
Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia
2001
The carcinogenicity of human papillomavirus types reflects viral evolution
2005
Regression of low-grade squamous intra-epithelial lesions in young women
2004
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Global Cancer Statistics, 2002
2005 Standout
Epidemiology of HPV infection among Mexican women with normal cervical cytology
2001
A high frequency of human papillomavirus DNA sequences in cervical carcinomas of indian women as revealed by southern blot hybridization and polymerase chain reaction
1992 StandoutNobel
Human papillomavirus variants and squamous neoplasia of the cervix
2001
Classification of papillomaviruses
2004 StandoutNobel
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study
1999
HPV testing in primary screening of older women
1999
Risk of High‐Grade Squamous Intraepithelial Lesion in HIV‐Infected Adolescents
2004
Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study
2003
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Prevalence of HPV Infection Among Females in the United States
2007 Standout
The Natural History of Human Papillomavirus Type 16 Capsid Antibodies among a Cohort of University Women
1996
Risk Factors for HPV DNA Detection in Middle-Aged Women
1996
The burden of non-communicable diseases in South Africa
2009 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative Women
1999
Seroprevalence atlas of infections with oncogenic and non‐oncogenic human papillomaviruses in Finland in the 1980s and 1990s
2006
Human Papillomavirus Infection and Time to Progression and Regression of Cervical Intraepithelial Neoplasia
2003
Nutrition and cervical neoplasia
1996
Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance
2002
The epidemiology of genital human papillomavirus infection
2005
Snakebite envenoming
2017 Standout
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
2007 Standout
Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer
1999
Genomic Variation of Human Papillomavirus Type 16 and Risk for High Grade Cervical Intraepithelial Neoplasia
1997
The molecular biology of head and neck cancer
2010 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
2004
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Effects of Bacterial Vaginosis and Other Genital Infections on the Natural History of Human Papillomavirus Infection in HIV‐1–Infected and High‐Risk HIV‐1–Uninfected Women
2005
Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12
2003
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
1997
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia
1997
A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica
2005
The causal relation between human papillomavirus and cervical cancer
2002 Standout
The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence
2005
Identification of Tobacco- Specific Carcinogen in the Cervical Mucus of Smokers and Nonsmokers
1997
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine
2003
Human papillomavirus and cervical cancer
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Combined human papillomavirus DNA and human papillomavirus‐like particle serologic assay to identify women at risk for high‐grade cervical intraepithelial neoplasia
2006
PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes
2000
Development and Duration of Human Papillomavirus Lesions, after Initial Infection
2005
Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings
2001
Contribution of focal haemorrhage and microvascular fibrin deposition to fatal envenoming by Russell's viper (Vipera russelli siamensis) in Burma
1989
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
2002
The natural history of cervical HPV infection: unresolved issues
2006
Papillomavirus and HPV typing
1997
Sexual Behavior and Partner Characteristics Are the Predominant Risk Factors for Genital Human Papillomavirus Infection in Young Women
1996
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein?based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
2004
Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
2003 Standout
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
1998 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
1997
A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
2000
Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study
2013
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus‐like particles in colombian women with invasive cervical cancer
2001
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance
2002
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study
2001
Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women
1999
Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident Infection
2000
Heritability of cervical tumours
2000
Effects of β-Carotene and Other Factors on Outcome of Cervical Dysplasia and Human Papillomavirus Infection
1997
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
2015 Standout
Human Papillomaviruses and cervical Cancer
1997
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Is HIV infection a cofactor for cervical squamous cell neoplasia?
1999
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Risk factors for cervical neoplasia in Denmark
1998
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.
2001
Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion
2005
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
1997
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2007 Standout
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method
1998
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Model for Assessing Human Papillomavirus Vaccination Strategies
2007
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Human Papillomavirus and Cervical Cancer
2003 Standout
Smokers at Higher Risk for Undetected Antibody for Oncogenic Human Papillomavirus Type 16 Infection
2006
A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
2000
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems
1997
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.
2001
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
2004
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
2003
Works of J Basu being referenced
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
1995
Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia.
1991
Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer.
1996
Acute renal failure following snake bite (viper).
1977